About this trial
Stress urinary incontinence (SUI) affects around 40% of women and has a major impact on quality of life. The gold standard for the treatment of SUI is pelvicfloor rehabilitation, but this presents constraints in terms of availability of healthcare professionals, as well as organization and travel for patients. Innovative devices offer self-training exercises for the pelvicfloor, thus promoting motivation and adherence to treatment. The hypothesis of this study is to prove that the use of a pelvicfloor medical device combined with 2 rehabilitation sessions is not inferior to pelvic-perineal rehabilitation.
Eligibility criteria
Qualifiers
Patients with moderate, severe or very severe stress urinary incontinence or mixed stress urinary incontinence (according to ICIQ-UI SF questionnaire score: moderate (6-12), severe (13-18) and very severe (19-21))
Patient aged between 18 and 60
Patient with a quality of life score measured with the I-QoL questionnaire less than or equal to 70 (score measured from 0 to 100, with poor quality of life: 0-35; average quality of life: 36-70; good quality of life: 71-100)
Not to have given birth in the last 6 months (to avoid post-partum physiological recovery)
Disqualifiers
Patients with mild stress urinary incontinence or mixed stress urinary incontinence (ICIQ-UI SF score: mild (1-5))
Patient with a quality of life score above 70 (according to the I-QoL questionnaire: good quality of life: 71-100)
Patient undergoing other pelvic-perineal rehabilitation during the study period
Patients with neurological disease or congenital malformation, surgically or medically treated urinary incontinence or prolapse, perineal hypoesthesia or local conditions prohibiting the use of an intravaginal catheter
Trial design
Treatments tested in this trial
- EMY
Treatment groups
Sponsors and collaborators
Nantes University Hospital
Lead sponsor
FIZIMED Company
Collaborator